Search Results 1181-1190 of 17212 for Green Birth Control

  1. A Study to Understand How the Inner Ear Balance Works and Develop a Tool to help Identify Inner Ear Balance Disorders - Mayo Clinic

    Control subjects: Must have no history of complaints of dizziness or imbalance and normal responses on ocular motor, positional, caloric and sinusoidal ...

  2. A Study to Compare the Effectiveness, Safety and Tolerability of P1101 vs. Anagrelide for Essential Thrombocythemia - Mayo Clinic

    ... birth control until 28 days following the last dose of the study drug, and females must agree to not breastfeed during the study 13. Written informed ...

  3. Clinical trials - Oncology (Medical)

    The purpose of this multicenter prospective observational case-control study is to train and validate Adela's cfMeDIP-seq based methylome profiling platform to ...

  4. Clinical trials - Oncology (Medical)

    A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

  5. Pediatrics Clinical Trials - Medical Professionals

    albicans in the microbial communities of a population of children at-risk for atopic dermatitis compared to healthy controls who do not have an underlying risk ...

  6. A Study to Analyze Leg Dexterity - Clinical Trials

    This study aims to establish the clinical feasibility and utility of using the Leg Dexterity test as an objective measure of recovery of neuromuscular control ...

  7. https://www.mayoclinic.org/organization_concepts.xml

  8. Mehrdad Hefazi Torghabeh, M.D. - Mayo Clinic Faculty Profiles

    Mehrdad Hefazi Torghabeh, M.D., focuses his research on myeloid malignancies and hematopoietic cell therapies, with particular emphasis on allogeneic stem cell ...

  9. Clinical trials - Oncology (Medical)

    ... population, with and without chronic gastroesophageal reflux disease. ... This study aims to determine cancer control at 2 years after study registration.

  10. Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Women of childbearing potential who do not agree to practice 2 different methods of birth control or remain abstinent during the trial and for 30 days after the ...